Jiangsu Hengrui Pharmaceuticals Co.Ltd (1276.HK) released a profit for its first quarter that Increased, from last year
The company's bottom line totaled RMB2.282 billion, or RMB0.34 per share. This compares with RMB1.874 billion, or RMB0.30 per share, last year.
The company's revenue for the period rose 13.0% to RMB8.141 billion from RMB7.206 billion last year.
Jiangsu Hengrui Pharmaceuticals Co.Ltd earnings at a glance (GAAP) :
-Earnings: RMB2.282 Bln. vs. RMB1.874 Bln. last year.-EPS: RMB0.34 vs. RMB0.30 last year.-Revenue: RMB8.141 Bln vs. RMB7.206 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.